...
首页> 外文期刊>Journal of pharmaceutical sciences. >In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches
【24h】

In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches

机译:体外血脑屏障模型-建立的模型和新的微流控方法概述

获取原文
获取原文并翻译 | 示例
           

摘要

The societal need for new central nervous system (CNS) medicines is substantial, because of the global increase in life expectancy and the accompanying increase in age-related CNS diseases. Low blood-brain barrier (BBB) permeability has been one of the major causes of failure for new CNS drug candidates. There has therefore been a great interest in cell models, which mimic BBB permeation properties. In this review, we present an overview of the performance of monocultured, cocultured, and triple-cultured primary cells and immortalized cell lines, including key parameters such as transendothelial electrical resistance values, permeabilities of paracellular flux markers, and expression of BBB-specific marker proteins. Microfluidic systems are gaining ground as a new automated technical platform for cell culture and systematic analysis. The performance of these systems was compared with current state-of-the-art models and it was noted that, although they show great promise, these systems have not yet reached beyond the proof-of-concept stage. In general, it was found that there were large variations in experimental protocols, BBB phenotype markers, and paracellular flux markers used. It is the author's opinion that the field may benefit greatly from developing standardized methodologies and initiating collaborative efforts on optimizing culture protocols. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2727-2746, 2015
机译:由于全球预期寿命的增加以及与年龄有关的中枢神经系统疾病的随之而来,社会上对新的中枢神经系统(CNS)药物的需求很大。低血脑屏障(BBB)渗透性已成为新的中枢神经系统药物候选药物失败的主要原因之一。因此,人们对模拟BBB渗透特性的细胞模型非常感兴趣。在这篇综述中,我们概述了单培养,共培养和三次培养的原代细胞和永生化细胞系的性能,包括关键参数,例如跨内皮电阻值,旁细胞通量标记的通透性以及BBB特异性标记的表达蛋白质。微流体系统作为用于细胞培养和系统分析的新型自动化技术平台,正在逐渐普及。将这些系统的性能与当前的最新模型进行了比较,并指出,尽管它们显示出很大的希望,但这些系统还没有超出概念验证阶段。通常,发现实验方案,BBB表型标记和旁细胞通量标记存在很大差异。作者认为,该领域可能会受益于开发标准化方法并启动有关优化文化协议的合作。 (c)2015年,Wiley Periodicals,Inc.和美国药剂师协会J Pharm Sci 104:2727-2746,2015

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号